Compound Specific Activity Formulation Product
TBq/mmol Ci/mmol (see key) code
[35S]dCTPαS >37 >1000 1 SJ1305
~22 ~600 1 SJ 305
~15 ~400 1 SJ 265
[35S]dGTPαS ~22 ~600 1 SJ 306
[35S]dTTPαS ~22 ~600 1 SJ 307
[8–3H]dATP 0.37–1.1 10–30 2 TRK 347
[1’,2’,2,8–3H]dATP 1.83–3.7 50–100 2 TRK 633
[1’,2’,5–3H]dCTP 1.85–3.14 50–85 2 TRK 625
[5–3H]dCTP 0.55–1.1 15–30 2 TRK 352
[8–3H]dGTP 0.185–0.740 5–20 2 TRK 350
[1’2,(–3H]dGTP 0.9–1.85 25–50 2 TRK 627
[methyl, 1’,2’–3H]TTP 3.3–4.8 90–130 2 TRK 576
[methyl–3H]TTP 40–60 2 TRK 424
30 2 TRK 354
[125I]dCTP >55 >1500 3 IM 5103
Formulation codes:
1) = 370 MBq/ml, 10 mCi/ml in stabilized solution
2) = 37 MBq/ml, 1 mCi/ml in 50% aqueous ethanol
3) = 185 MBq/ml, 5 mCi/ml in 50% aqueous ethanol
See GE Healthcare Products catalogue for further details.
41